DEANNA TWYMAN: Open Payments
NPI 1164408399 · CONWAY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 9 payments from 6 companies in 2025. Trend: 2023 $158 · 2024 $447 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $33 |
| Verona Pharma, Inc. | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: REXULTI, VRAYLAR, Ohtuvayre, ZENPEP, Ozempic, GARDASIL 9.
Industry payments across MO — which companies pay providers there.
